Common Protocol: Tesamorelin: 1 mg daily, subcutaneous BPC-157: 250500 mcg daily TB500: 25 mg per week Cycle: 812 weeks, often used post-injury or during high-recovery phases Key Notes: Peptides can be cycled to avoid desensitization and maintain effectiveness
By 2008, the manufacturer (Palatin Technologies) halted nasal formulation trials and pivoted to a subcutaneous injection route, which showed fewer cardiovascular side effects
Every batch is analysed in-house by HPLC and mass spectrometry and ships with a batch-specific Certificate of Analysis
Each capsule contains 500mcg of BPC-157 and 500mcg of TB-500, for a total standardized research peptide blend of 1000mcg per capsule
Here are some of the most common reasons for vitamin B12 deficiency: Pernicious Anemia This is the most common cause of vitamin B12 deficiency worldwide and mainly affects people of Northern European ancestry
We require comprehensive Blood Work before starting any protocol to ensure the stack is safe and appropriate for your individual physiology
